Mike A. Royal

Mike Royal is a senior pharmaceutical executive with over 30 years of experience in the drug development process with expertise in clinical research and medical and regulatory affairs. He has been responsible for clinical trial oversight from phase 1 through phase 4, including multi-site/multi-country trials, and has an established track record for innovative solutions to development obstacles. Mike has been instrumental in setting product launch and lifecycle management strategies and successfully submitted NCE and 505(b)(2) NDAs across several indications as well as ANDAs. He is board-certified in internal medicine, anesthesiology, pain management, and addiction medicine and has over 190 peer-reviewed publications, book chapters, and abstracts/posters.